Skip To Main Content

This website is intended exclusively for Southern Africa healthcare professionals only.

Campus

Newsletters

Login
Registration

Science
Antimicrobials
Asthma
Multiple Sclerosis
Neurology
Rare Diseases
Thrombosis

Atopic Dermatitis
The Science of Type 2 Inflammation
Treating to Target
Patient Information
Dupixent
Support Tools and Information

Diabetes
2024 GP Care Annual Forum VODs

Vaccines
Meningitis
Pertussis
Influenza
Hepatitis A
Rabies
Newsletters

Patient Support
Asthma
Atopic Dermatitis
Diabetes

Multiple Sclerosis

Risk Management Programme
Aubagio
Auberif

Products
Aldurazyme®
Cerezyme®
Dupixent
Elaprase®
Epilim®
Epilizine®
Fabrazyme®
Hexaxim®
Irbewin® and Co-Irbewin®
iXarola®
Menactra
Myozyme®
Praluent

Adacel
ADACEL® for Maternal Immunization: Protecting Infants from Pertussis
ADACEL® Tdap Vaccination in Pregnancy: Protecting Infants from Whooping Cough
Pregnancy Vaccination Guide: Protecting Mother and Baby from Whooping Cough
Protect Your Baby: Whooping Cough Vaccination During Pregnancy | Circle of Protection
Adacel® TDaP Vaccine: Boosting Immunity Against Tetanus, Diphtheria & Pertussis
Continue the Circle of Protection: Childhood Vaccination Boosters for Diphtheria, Tetanus, and Whooping Cough

Aubagio®
Aubagio®

Avaxim 160
Avaxim 160

Lemtrada®

Lemtrada
Dosing Guide

Soliqua
T2DM with SOLIQUA®

Stilnox MR
Stilnox MR

Toujeo
TOUJEO Clinical Justification - upgrade from U-100 to GLA-300
Adults, adolescents and children from the age of 6 years with Type 1 or Type 2 Diabetes Mellitus requiring basal insulin

Urbanol
Urbanol

VaxigripTetra
VaxigripTetra

Events
Diabetes

Campus

Newsletters

Science
Antimicrobials
Asthma
Multiple Sclerosis
Neurology
Rare Diseases
Thrombosis

Atopic Dermatitis
The Science of Type 2 Inflammation
Treating to Target
Patient Information
Dupixent
Support Tools and Information

Diabetes
2024 GP Care Annual Forum VODs

Vaccines
Meningitis
Pertussis
Influenza
Hepatitis A
Rabies
Newsletters

Patient Support
Asthma
Atopic Dermatitis
Diabetes

Multiple Sclerosis

Risk Management Programme
Aubagio
Auberif

Products
Aldurazyme®
Cerezyme®
Dupixent
Elaprase®
Epilim®
Epilizine®
Fabrazyme®
Hexaxim®
Irbewin® and Co-Irbewin®
iXarola®
Menactra
Myozyme®
Praluent

Adacel
ADACEL® for Maternal Immunization: Protecting Infants from Pertussis
ADACEL® Tdap Vaccination in Pregnancy: Protecting Infants from Whooping Cough
Pregnancy Vaccination Guide: Protecting Mother and Baby from Whooping Cough
Protect Your Baby: Whooping Cough Vaccination During Pregnancy | Circle of Protection
Adacel® TDaP Vaccine: Boosting Immunity Against Tetanus, Diphtheria & Pertussis
Continue the Circle of Protection: Childhood Vaccination Boosters for Diphtheria, Tetanus, and Whooping Cough

Aubagio®
Aubagio®

Avaxim 160
Avaxim 160

Lemtrada®

Lemtrada
Dosing Guide

Soliqua
T2DM with SOLIQUA®

Stilnox MR
Stilnox MR

Toujeo
TOUJEO Clinical Justification - upgrade from U-100 to GLA-300
Adults, adolescents and children from the age of 6 years with Type 1 or Type 2 Diabetes Mellitus requiring basal insulin

Urbanol
Urbanol

VaxigripTetra
VaxigripTetra

Events
Diabetes

Login
Registration

Search Term

View Full Results

Meet Sanofi Medical

Campus

social links

Back to top

Privacy Policy Legal Notice Cookie Policy Sitemap

© Sanofi 2004- - All rights reserved

Sanofi Floor 5, Building I, Hertford Office Park, 90 Bekker Road, Midrand, 2196
Tel: +27 (0)11 256 3700
Contacts For Prescription Medicines:
For Adverse Event reporting: ZA.drugsafety@sanofi.com
For Medical Information Enquiries:
Related to General Medicine and Speciality Care products: ZA.Medinfo@sanofi.com
Related to Pasteur / Vaccines: ZAvaccine.queries@sanofi.com
For Product Technical Complaints: SouthAfrica.PTC@sanofi.com
Contacts For Consumer Health Care (Over The Counter Products):
CHC Office Address: Floor 4, Building I, Hertford Office Park, 90 Bekker Road, Midrand, 2196 Sanofi Medicines

For Adverse Event reporting: za.CHCdrugsafety@sanofi.com
For Medical Information Enquiries: ZA.CHCenquiries@sanofi.com
For Product Technical Complaints: CHC-ZAQAComplaints@sanofi.com